T. Mihaescu (Iasi, Romania), M. T. El Fassy Fihry (Rabat, Morocco)
Choice and adherence in preventive treatment for tuberculosis
T. W. Rennie, G. H. Bothamley, D. Engova (London, United Kingdom)
|  |
TB failures, risk factors and therapeutical results
M. V. Cirstoniu, D. C. Todea (Cluj-Napoca, Romania)
| |
Treatment results of relapses of pulmonary tuberculosis in Iasi County between 1998–2001
C. Grigoras (Iasi, Romania)
| |
Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
S. A. Cherenko, B. V. Radionov, E. R. Tarasenko (Kiev, Ukraine)
| |
Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
M. B. N. B. Prasad, K. Shashirekha, R. K. Choudhary (New Delhi, Ranchi, India)
| |
The main causes which are responsible for secondary chemoresistance of Mycobacterium tuberculosis
R. M. Gherasim, C. M. Pop, C. D. Zamora (Cluj-Napoca, Romania)
| |
Resistance patterns of mycobacterium tuberculosis complex isolates in the Turkish Army from 1998–2000
M. A. Saracli, A. Albay, C. Guney, A. Alp, F. Ciftci, L. Doganci (Ankara, Istanbul, Turkey)
| |
Tuberculous bacillus drug resistance in hospitalized patients with drug resistant tuberculosis in Massih Daneshvari Hospital
M. R. Masjedi, M. Amiri, S. M. Mirsaeidi, K. Mohajer, S. D. Mansouri, A. A. Velayati (Tehran, Iran)
| |
Antituberculosis activity of rifabutin in vitro and in patients with pulmonary drug resistant tuberculosis
I. B. Byalik, L. M. Tsygankova, Z. E. Vyalykh, A. I. Barbova, E. R. Tarasenko, V. V. Davidenko (Kiev, Ukraine)
| |
Safety and efficacy of supervised chemotherapy in Indian patients having multi-drug resistant tuberculosis
S. K. Agarwal (Varanasi, India)
| |
Resistance rates of Mycobacterium tuberculosis to first-line antituberculosis drugs. Trends in Greece during the period 1991–2000
E. Marinis, C. Costopoulos, S. Nicolaou, A. Skroumbelou, E. Varonou, S. Anagnostou, M. Toumbis, E. Vogiatzakis (Athens, Greece)
| |
Treatment possibilities of multi-drug resistant (MDR) tuberculosis
S. Pavlovic, V. Kuruc, M. Ilic, A. Vukelic (Sremska Kamenica, Yugoslavia)
| |
Application of thoracoplasty in the treatment of multi-drug resistant fibro-cavernous TB in prisoners
K. B. Vladimirov, S. D. Kochorov, S. I. Sokolov, A. I. Grinblat (St Petersburg, Russia)
| |
Smoking and drug-resistant tuberculosis
C. I. Oprea, M. C. Ciontu, A. V. Halpern, L. Spalatelu (Bucharest, Romania)
| |
Treatment results of 44 patients with MDR-TB
F. Sungun, A. Saygi, E. U. Tugtepe, G. Dabak, D. E. Demircan Alici, E. Ozturk (Istanbul, Turkey)
| |
Secondary chimioresistance (SC) in patients registered with tuberculosis in Cluj county in 2001
V. Muresan (Cluj-Napoca, Romania)
| |
Cost-effectiveness analysis of regimens chemotherapy in patients with multidrug resistant tuberculosis (MDR TB) compared with standard regimen in patients with susceptible MBT
I. V. Sluch (Kiev, Ukraine)
| |